PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative Biopsy
NCT06923657 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 230
Last updated 2025-09-15
Summary
The goal is to provide more accurate diagnostic tools and optimized diagnostic workflows for clinically suspected prostate cancer patients with prior negative biopsies, improving early detection rates for csPCa and reducing missed diagnoses.
Conditions
- Prostate Cancer Screening
- PSMA-PET
Interventions
- DIAGNOSTIC_TEST
-
PSMA PET/MRI-TRUS guided prostate targeted combined saturation biopsy
The experimental group will undergo PSMA PET/MRI examination. For those with positive PSMA PET/MRI results, a PSMA PET/MRI-TRUS guided prostate targeted biopsy will be performed based on transrectal ultrasound (TRUS) guided transperineal saturation biopsy, targeting the positive lesions. For those with negative PSMA PET/MRI results, only TRUS guided transperineal saturation biopsy will be performed. Clinical and pathological data of the patients will be collected for statistical analysis.
- DIAGNOSTIC_TEST
-
TRUS guided transperineal saturation biopsy
The control group will receive TRUS guided transperineal saturation biopsy. Clinical and pathological data of the patients will be collected for statistical analysis.
Sponsors & Collaborators
-
First Affiliated Hospital of Fujian Medical University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 85 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-07
- Primary Completion
- 2026-05-01
- Completion
- 2026-12-01
Countries
- China
Study Locations
More Related Trials
-
A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer
NCT06696326 ·Status: RECRUITING ·Phase: NA
-
Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection
NCT03572946 ·Status: UNKNOWN ·Phase: NA
-
a Study of Combined mpMRI and PSMA PET/CT for Highly Suspicious Patients Performing Radical Prostatectomy Without Biopsy
NCT05670691 ·Status: UNKNOWN
-
A Research for Combination of Prostate Health Index (Phi) and mpMRI PI-RADS in the Diagnosis of Prostate Cancer
NCT05179707 ·Status: UNKNOWN
-
The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate Cancer
NCT06824259 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study of 68Ga-GRP PET/CT for Imaging in Low and Intermediate Risk Prostate Cancer
NCT05073653 ·Status: UNKNOWN ·Phase: NA
-
68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients
NCT05324332 ·Status: RECRUITING ·Phase: NA
-
Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer.
NCT06355843 ·Status: SUSPENDED ·Phase: NA
-
Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients
NCT06690970 ·Status: RECRUITING
-
68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients
NCT04796467 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image Features
NCT06604377 ·Status: COMPLETED
-
Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient
NCT05422105 ·Status: UNKNOWN
-
The Application Value of Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA Grey Area Prostate Cancer
NCT05958004 ·Status: COMPLETED
-
Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer
NCT06919159 ·Status: COMPLETED
-
PSMA PET/CT vs. mpMRI in Patients With a High Suspicion of Prostate Cancer: a Head to Head, Parallel, Prospective Trial
NCT05297162 ·Status: UNKNOWN ·Phase: NA
-
Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT05955677 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Radical Prostatectomy Without Prostate Biopsy Following PSMA PET/CT Based on Diagnostic Model
NCT05587192 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
68Ga-AAZTA-093 PET/CT: First-in-human Study
NCT06437496 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
99mTc-P137 SPECT/CT in Prostate Cancer
NCT05672485 ·Status: RECRUITING ·Phase: NA
-
The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients
NCT06723665 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT06462495 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
GUidance In Prostate Cancer DEtection With 18F-PSMA-1007-PET/MRI and Targeted Biopsies
NCT07258056 ·Status: RECRUITING ·Phase: NA
-
Correlation of Imaging Findings With Clinical Findings and Patient Outcomes in Prostate Cancer
NCT03122470 ·Status: WITHDRAWN ·Phase: NA
-
Sequential bpMRI for Suspicious Prostate Lesions
NCT07332832 ·Status: NOT_YET_RECRUITING
-
Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT06462508 ·Status: RECRUITING ·Phase: EARLY_PHASE1